LTB4 SWEDEN AB has a total of 18 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are COMPREHENSIVE AND INTEGRATIVE MEDICINE INST, BIOLIFE SCIENCE QLD LTD and GANSU PROVINCIAL HOSPITAL OF TCM.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | Hong Kong | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Norway | 1 | |
#11 | Taiwan | 1 | |
#12 | Ukraine | 1 | |
#13 | United States | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Borgeat Pierre | 13 |
#2 | Flamand Louis | 3 |
#3 | Gosselin Jean | 3 |
#4 | Horvath Karol | 3 |
#5 | Pierre Borgeat | 2 |
Publication | Filing date | Title |
---|---|---|
ZA200702798B | Stabilized leukotriene B4 (LTB4) agent pharmaceutical | |
EP1840114A1 | Crystalline Leukotriene B4 | |
CA2581156A1 | Stabilized leukotriene b4 (ltb4) agent pharmaceutical formulation | |
WO2004112795A1 | Ltb4 compositions for treating tract infections |